Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Long-Term Debt Issuances: 2018-2019

Historic Long-Term Debt Issuances for EyePoint Pharmaceuticals (EYPT) over the last 1 years, with Mar 2019 value amounting to $35.0 million.

  • EyePoint Pharmaceuticals' Long-Term Debt Issuances rose 133.33% to $35.0 million in Q1 2019 from the same period last year, while for Mar 2019 it was $90.0 million, marking a year-over-year change of. This contributed to the annual value of $30.0 million for FY2022, which is N/A change from last year.
  • According to the latest figures from Q1 2019, EyePoint Pharmaceuticals' Long-Term Debt Issuances is $35.0 million, which was up 75.00% from $20.0 million recorded in Q3 2018.
  • In the past 5 years, EyePoint Pharmaceuticals' Long-Term Debt Issuances ranged from a high of $35.0 million in Q1 2019 and a low of $15.0 million during Q1 2018.
  • For the 2-year period, EyePoint Pharmaceuticals' Long-Term Debt Issuances averaged around $22.5 million, with its median value being $20.0 million (2018).
  • Data for EyePoint Pharmaceuticals' Long-Term Debt Issuances shows a peak YoY surged of 133.33% (in 2019) over the last 5 years.
  • Quarterly analysis of 2 years shows EyePoint Pharmaceuticals' Long-Term Debt Issuances stood at $20.0 million in 2018, then soared by 133.33% to $35.0 million in 2019.
  • Its last three reported values are $35.0 million in Q1 2019, $20.0 million for Q3 2018, and $20.0 million during Q2 2018.